Cite

    Hermine I Brunner et al.. “Subcutaneous golimumab for children with active polyarticular-course juvenile idiopathic arthritis: results of a multicentre, double-blind, randomised-withdrawal trial.” Annals of the rheumatic diseases, vol. 77, no. 1, 2018, pp. 21–29. http://access.bl.uk/ark:/81055/vdc_100137788822.0x000062